Invasive Candidiasis in Critically Ill Patients: A Prospective Cohort Study in Two Tertiary Care Centers.
Hasan M Al-DorziHussam SakkijhaRaymond KhanTarek AldabbaghAron ToledoPendo NtinikaSameera M Al JohaniYaseen M ArabiPublished in: Journal of intensive care medicine (2018)
In critically ill patients with invasive candidiasis, non-albicans was responsible for most cases, and mortality was high (58.6%). Antifungal therapy was initiated after culture results in 60% suggesting low preclinical suspicion. Study registration: NCT01490684; registered in ClinicalTrials.gov on February 11, 2012.